These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17502291)

  • 1. Observation versus intervention in the evaluation of drugs: the story of hormone replacement therapy.
    Costagliola D
    C R Biol; 2007 Apr; 330(4):347-55. PubMed ID: 17502291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone therapy--weighing up the evidence.
    Teede HJ
    Aust Fam Physician; 2004 Nov; 33(11):875-80. PubMed ID: 15584324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 5. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE; Bassuk SS
    Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evidence of hormone replacement therapy for osteoporosis].
    Tarakida A; Higuchi T; Mizunuma H
    Clin Calcium; 2008 Oct; 18(10):1434-41. PubMed ID: 18830040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can menopausal hormone therapy prevent coronary heart disease?
    Brinton EA; Hodis HN; Merriam GR; Harman SM; Naftolin F
    Trends Endocrinol Metab; 2008 Aug; 19(6):206-12. PubMed ID: 18450469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy.
    Dull P
    Prim Care; 2006 Dec; 33(4):953-63. PubMed ID: 17169676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sound and the fury: was it all worth it?
    Hoover RN
    Epidemiology; 2008 Nov; 19(6):780-2; discussion 789-93. PubMed ID: 18813016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRT and cardiovascular disease.
    Stevenson JC
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):109-20. PubMed ID: 19095500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The medical management of menopause: to treat or not to treat?
    Barlow DH
    Ann N Y Acad Sci; 2008 Apr; 1127():134-9. PubMed ID: 18443341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuing postmenopausal hormone therapy: an observational study of tapering versus quitting cold turkey: is there a difference in recurrence of menopausal symptoms?
    Haskell SG; Bean-Mayberry B; Gordon K
    Menopause; 2009; 16(3):494-9. PubMed ID: 19182695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of hormone therapy in the 50-59 year age group.
    van de Weijer PH
    Maturitas; 2008 May; 60(1):59-64. PubMed ID: 18556157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conventional hormonal replacement therapy in treatment of osteoporosis].
    Meczekalski B; Czyzyk A
    Pol Merkur Lekarski; 2009 Jul; 27(157):72-6. PubMed ID: 19650436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy for menopausal symptoms: putting benefits and risks into perspective.
    Warren MP
    J Fam Pract; 2010 Dec; 59(12):E1-7. PubMed ID: 21135919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The general practitioner's view on hormone replacement therapy during and after menopause].
    Gjelsvik B; Swensen E; Hjortdahl P
    Tidsskr Nor Laegeforen; 2007 May; 127(11):1500-3. PubMed ID: 17551553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.